TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway.

Biochemical Genetics
Jingjing QiaoJing Yu

Abstract

Breast cancer is the most common cancer in women worldwide, and advanced breast cancer is the leading cause of cancer death in women. In present study, we aim to investigate that role of T-cell lymphoma invasion and metastasis-inducing protein1 (TIAM1) on NVP-BEZ235 resistance to breast cancer MCF7 and MDA-MB-361 cells. Briefly, MCF7 and MDA-MB-361 cells were treated with NVP-BEZ235 and the relative expressions of TIAM1 at both mRNA level and protein level were determined by RT-PCR and western blot. In addition, MCF7 and MDA-MB-361 cells were transfected with TIAM1 knockdown or overexpression vector. Then the IC50 of NVP-BEZ235 on MCF7 and MDA-MB-361 cells were detected by MTT assay. Finally, FGFR/STAT3 pathway protein members were investigated by western blot. Consequently, we found that the mRNA and protein expressions of TIAM1 and FGFR1/3 were dramatically upregulated in NVP-BEZ235-treated group in both MCF7 and MDA-MB-361 cells. Interestingly, TIAM1 knockdown via shRNA decreased the IC50 of NVP-BEZ235 of breast cancer cells, while TIAM1 overexpression increased the IC50 of NVP-BEZ235 of breast cancer cells, which suggested that TIAM1 was one of the contributors for NVP-BEZ235 resistance. In addition, FGFR members including ...Continue Reading

References

Jul 2, 2003·Proteomics·Shiaw-Lin WuSteven T Kunitake
Aug 12, 2009·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Arturo PradoFrancisco Parada
Dec 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Saskia M BrachmannSauveur-Michel Maira
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nina IlicThomas M Roberts
Sep 27, 2012·Molecular Cancer Therapeutics·Jaime AcquavivaDavid A Proia
May 3, 2013·The Journal of Clinical Investigation·Violeta SerraJosé Baselga
Mar 29, 2014·Breast Cancer : Basic and Clinical Research·Sebastian KugerCholpon S Djuzenova
Apr 20, 2014·Cancers·Richard L Carpenter, Hui-Wen Lo
Jan 30, 2016·Breast Cancer Research : BCR·Kun XuRachel J Buchsbaum
Jul 2, 2017·Breast Cancer Research : BCR·Meghan Morrison JolyRebecca S Cook
Mar 21, 2019·Cell Death & Disease·Daisuke IzumiAjay Goel
Mar 28, 2019·Nature Communications·Luigi FormisanoCarlos L Arteaga

❮ Previous
Next ❯

Citations

Oct 22, 2020·Cancers·Maria Francesca Santolla, Marcello Maggiolini
Jul 29, 2021·Journal of Drug Targeting·Yingying LiGuangxi Zhai

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
Protein Assay
electrophoresis

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.